PureTech Health plc (PRTC.L)
GBp 164.0
(2.5%)
GBp 164.0
(2.5%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 235.74 Million USD | 52.03% |
| 2022 | 155.05 Million USD | -57.15% |
| 2021 | 361.85 Million USD | 7.55% |
| 2020 | 336.45 Million USD | 15.71% |
| 2019 | 290.78 Million USD | 5.82% |
| 2018 | 274.79 Million USD | -0.38% |
| 2017 | 275.84 Million USD | 33.69% |
| 2016 | 206.33 Million USD | 26.82% |
| 2015 | 162.7 Million USD | 72.46% |
| 2014 | 94.34 Million USD | 280.51% |
| 2013 | 24.79 Million USD | 10.0% |
| 2012 | 22.53 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 273.74 Million USD | 0.0% |
| 2024 Q1 | 273.74 Million USD | 16.12% |
| 2023 Q1 | 184.66 Million USD | 19.09% |
| 2023 Q3 | 235.74 Million USD | 27.66% |
| 2023 Q2 | 184.66 Million USD | 0.0% |
| 2023 FY | 235.74 Million USD | 52.03% |
| 2023 Q4 | 235.74 Million USD | 0.0% |
| 2022 Q3 | 155.05 Million USD | -37.26% |
| 2022 FY | 155.05 Million USD | -57.15% |
| 2022 Q4 | 155.05 Million USD | 0.0% |
| 2022 Q1 | 247.12 Million USD | -31.71% |
| 2022 Q2 | 247.12 Million USD | 0.0% |
| 2021 Q3 | 361.85 Million USD | 7.85% |
| 2021 FY | 361.85 Million USD | 7.55% |
| 2021 Q2 | 335.51 Million USD | 0.0% |
| 2021 Q1 | 335.51 Million USD | -0.28% |
| 2021 Q4 | 361.85 Million USD | 0.0% |
| 2020 Q1 | 338.64 Million USD | 16.46% |
| 2020 FY | 336.45 Million USD | 15.71% |
| 2020 Q2 | 338.64 Million USD | 0.0% |
| 2020 Q3 | 336.45 Million USD | -0.65% |
| 2020 Q4 | 336.45 Million USD | 0.0% |
| 2019 Q4 | 290.78 Million USD | 0.0% |
| 2019 Q3 | 290.78 Million USD | -29.2% |
| 2019 Q2 | 410.69 Million USD | 0.0% |
| 2019 Q1 | 410.69 Million USD | 49.46% |
| 2019 FY | 290.78 Million USD | 5.82% |
| 2018 Q2 | 217.81 Million USD | 0.86% |
| 2018 FY | 274.79 Million USD | -0.38% |
| 2018 Q4 | 274.79 Million USD | 3.4% |
| 2018 Q3 | 265.76 Million USD | 22.01% |
| 2018 Q1 | 215.95 Million USD | -21.71% |
| 2017 Q2 | 236.8 Million USD | 0.99% |
| 2017 Q1 | 234.47 Million USD | 13.64% |
| 2017 FY | 275.84 Million USD | 33.69% |
| 2017 Q4 | 275.84 Million USD | 0.73% |
| 2017 Q3 | 273.86 Million USD | 15.65% |
| 2016 Q1 | 185.75 Million USD | 14.17% |
| 2016 Q3 | 204.08 Million USD | 8.58% |
| 2016 FY | 206.33 Million USD | 26.82% |
| 2016 Q4 | 206.33 Million USD | 1.11% |
| 2016 Q2 | 187.96 Million USD | 1.19% |
| 2015 Q2 | 119.76 Million USD | 0.79% |
| 2015 Q4 | 162.7 Million USD | 1.36% |
| 2015 FY | 162.7 Million USD | 72.46% |
| 2015 Q1 | 118.81 Million USD | 25.95% |
| 2015 Q3 | 160.52 Million USD | 34.03% |
| 2014 FY | 94.34 Million USD | 280.51% |
| 2014 Q3 | 93.67 Million USD | 0.0% |
| 2014 Q4 | 94.34 Million USD | 0.71% |
| 2014 Q1 | - USD | 0.0% |
| 2013 FY | 24.79 Million USD | 10.0% |
| 2012 FY | 22.53 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|